New Milbemycins from Streptomyces hygroscopicus subsp. aureolacrimosus. Fermentation, Isolation and Structure Elucidation.

Koichi Nonaka, Takahiro Tsukiyama, YOSHIHIRO OKAMOIO, Kazuo Sato, Chieko Kumasaka, Takahiro Yamamoto, Fumio Maruyama, Hiroji Yoshikawa

The Journal of Antibiotics · 2000 · 34 citations · 4 references

DOIFull text

Open access

Concepts

Abstract

Twelve new milbemycins have been isolated and characterized from some strains derived from Streptomyces hygroscopicus subsp. aureolacrimosus SANK 60286 and SANK 60526. The metabolites 1 approximately 4 and 9 approximately 11 were produced by strain RM28D-688 SANK 60797 as minor products. The metabolites 5 approximaetly 8 were obtained from a broth of strain 57-338 SANK 61796. Strain MK-1391 SANK 62896 was used for the production of metabolite 12. The new metabolites, eight alpha-class and four beta-class compounds, have new structural features. For example, milbemycins alpha26 and alpha27, have the 26-hydroxy moiety, and other derivatives (milbemycins alpha20 approximately 23) have different side chains at the C-26 position from those of milbemycins alpha11 and alpha14. In addition, 5-hydroxylmilbemycin beta7 (beta12), involved in the major biosynthetic pathway of 25-methyl and 25-ethyl milbemycins, was discovered.

References

4